Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Lean Lab rebrands to reflect its evolution within education innovation
The Lean Lab has announced a rebranding effort to better reflect and differentiate it from other groups in education innovation, said co-founder Katie Boody. Unveiling a new look in late April, the Kansas City-based organization is now LEANLAB Education, which Boody hopes will better communicate its mission, she said. “We know the nature of our…
H3 win at Regnier challenge puts Roy Scott $20K closer to his slice of $3B edtech market
The oversized novelty checks are piling up at H3 Enterprises’ headquarters in the Crossroads. Founder Roy Scott secured another $20,000 in prize money Friday, winning top honors in the Regnier Venture Creation Challenge. “We are continuing to grow and preparing to launch our new technology in schools across the country,” he said in social media…
Fund Me, KC: WISE IoT tech aims to lower energy bills, decrease carbon footprint
Editor’s note: Startland News is continuing its “Fund Me, KC” feature to highlight area entrepreneurial efforts to accelerate businesses or projects. If you or your startup is running a crowdfunding campaign, let us know by contacting news@startlandnews.com. Today’s featured campaign is from Kansas City-based Wise Power Inc. Who are you? My name is Kevin Williams…
Wonder Shops and Flats set to bring Blip Roasters, Bike Walk KC, medical group to Troost
Wonder what’s in the works at 30th and Troost? This weekend’s Wanderfest provides the opportunity for a sneak peek at a long-awaited development in one of Kansas City’s in-progress revitalization corridors. The Wonder Shops and Flats serves as a key stop during Sunday’s festivities, which showcase maker and creative work in the Tower East neighborhood.…